Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > In need of an update…
View:
Post by Year3000 on Jun 14, 2022 7:07pm

In need of an update…

On the 14/12/21
This week? Meeting with a potential strategic partner in Japan, reviewing some data from preliminary testing at Monastrerium (this is a 3-month project), working on  yet another grant application, reviewing new patent issuances, talking to potential new investors, etc.


..it's been 6 months since this tweet.... wtf is happening with the derma precise??? 


On 18/10/2021

RepliCel Files Arbitration against Shiseido to Resolve its License Dispute Regarding its Androgenetic Alopecia Cell Therapy

we are almost at 9 months since this was tweeted - granted they said it could take up to 1 year for the arbitration- surely there will be some news on this shortly

:(

Comment by Ingiboy on Jun 14, 2022 9:00pm
That is an understatement !   It looks like they have decided that there will not be any updates or tweets until they have some positive news to release.  Not sure about negative news because it seems like there has been some bad news but they are not releasing it.  I think they have become sensitive to making time predictions and not delivering which we have seen frequently. It is ...more  
Comment by Year3000 on Jun 14, 2022 9:14pm
I think there is a problem with the device too. But what I would have thought is that the lab reported back the problem to Replicel, Replicel fixes the problem (maybe another couple of months and then resubmits it for testing.  on another note... what ever happened to a new strategic partner in Japan? Think this will come in after the shiseido arbitration or do you think they are full of ...more  
Comment by Ingiboy on Jun 15, 2022 10:04am
I am stunned that they have not given us an update on the dermal injector.  There is obviously some issue holding up the submission for FDA Approval.  If they think it will negatively affect the share price we can't get much lower than $.10 - $.12. For the Shiseido Arbitration I assume the legal team representing Replicel have told them do not make any comments while the Arbitration ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities